Get Started

AZR

NASD Azora Therapeutics, Inc.
Nov 6, 2026 · 11:39 AM ET DELAYED Market Open

$3.89 ↑ +0.18 (+4.85%) Trading Up from the previous close of $3.71, $0.09 below the day’s high of $3.99

YTD change
-20.29%
vs 20-day SMA
N/A
vs 200-day SMA
N/A

Price ranges

Previous day
$3.71 $4.04
open $4.04 close $3.71
-$0.33 (-8.17%)
Today
$3.80 $3.99
open $3.91 now $3.89
-$0.02 (-0.51%)
Past week
$3.02 $4.94
from $4.88 now $3.89
-$0.99 (-20.29%)
Past month
$0.00 $4.88
from $4.88 now $3.89
-$0.99 (-20.29%)
This year
$3.02 $4.97
from $4.88 now $3.89
-$0.99 (-20.29%)

Price & Performance

-1.17 (-23.98%) / 6M

$3.62$4.07$4.52$4.97Oct 29Nov 2Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 55.5% away from all-time highs of $8.75
  • AZR is down 20% since the beginning of the year
  • AZR is down 20% over the past 12 months
  • AZR is down 20% over the past 1 month

AZR reads n/a: the 12-month move is -24.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-11.25
Earnings momentum -3650.0% Quarterly EPS growth
Quarterly change -3650.0%

Valuation

P/E ratio N/A
Enterprise value $50.8M
Beta 1.19

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$28.7M
Debt$62.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $50.1M

Azora Therapeutics, Inc. is a biopharmaceutical company that develops therapies for immune-mediated inflammatory diseases. Its investigational oral drug, AT177, is being develop for inflammatory bowel diseases, with an initial focus on ulcerative colitis. The company was founded by Julie Saiki and Matthew Davidson which is headquartered in Los Angeles, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $460.28 -3.80%
MRNA Moderna, Inc. $241.46 -6.55%
RVMD Revolution Medicines, Inc. $177.65 -11.04%
ROIV Roivant Sciences Ltd. $36.62 -4.21%
BNTX BioNTech SE Sponsored ADR $85.86 -5.34%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.